Valuation: Cenra Inc.

Market Cap 4.87B 151M 132M 123M 113M 212M 14.57B 217M 1.47B 573M 7.13B 566M 554M 24.73B P/E 2024
15.1x
P/E 2025 14x
Enterprise Value 7.13B 221M 194M 180M 166M 311M 21.32B 317M 2.15B 839M 10.43B 828M 811M 36.18B EV / Sales 2024
0.9x
EV / Sales 2025 0.83x
Free-Float
61.28%
Yield 2024
2.72%
Yield 2025 3.01%
1 day-3.75%
1 week-4.17%
Current month-4.58%
1 month-3.75%
3 months+2.93%
6 months-1.62%
Current year-0.15%
1 week 33.25
Extreme 33.25
35.1
1 month 33.25
Extreme 33.25
35.9
Current year 31.55
Extreme 31.55
36.6
1 year 31.55
Extreme 31.55
36.6
3 years 29
Extreme 29
44.55
5 years 29
Extreme 29
44.55
10 years 29
Extreme 29
44.55
Manager TitleAgeSince
Chief Executive Officer - 2020-11-04
Director of Finance/CFO - 2014-03-06
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member - 2016-05-26
Chairman - 2020-11-04
Director/Board Member - 2020-01-16
Change 5-day change 1-year change 3-year change Capi.($)
-3.75%-4.17%-3.89% - 156M
+0.57%+0.13%+16.45%+78.10% 48.31B
-0.50%-0.41%+67.13%+107.90% 35.33B
-1.56%-3.13%-4.88%+32.80% 11.85B
-1.11%-3.73%+16.41%+81.64% 11.64B
-0.37%-0.19%+36.48%+136.73% 8.99B
-0.27%+0.42%+51.66%-6.22% 6.93B
-0.77%-3.00%+13.55%+32.01% 6.72B
+0.24%-4.02%+2.19%+192.78% 6.43B
+1.60%-9.55%-30.77%+8.47% 5.66B
Average -0.59%-1.72%+16.43%+73.80% 14.2B
Weighted average by Cap. -0.15%-0.93%+27.57%+81.86%

Financials

2024 2025
Net sales 8.92B 276M 242M 225M 207M 388M 26.67B 397M 2.69B 1.05B 13.04B 1.04B 1.01B 45.26B 8.57B 265M 233M 216M 199M 373M 25.62B 381M 2.58B 1.01B 12.53B 996M 975M 43.49B
Net income 317M 9.83M 8.63M 8.02M 7.37M 13.82M 949M 14.11M 95.7M 37.33M 464M 36.87M 36.09M 1.61B 300M 9.29M 8.16M 7.58M 6.97M 13.07M 897M 13.34M 90.49M 35.3M 439M 34.87M 34.13M 1.52B
Net Debt 2.46B 76.09M 66.78M 62.06M 57.07M 107M 7.35B 109M 741M 289M 3.59B 285M 279M 12.47B 2.26B 69.88M 61.33M 57M 52.42M 98.29M 6.75B 100M 681M 265M 3.3B 262M 257M 11.45B
Logo Cenra Inc.
Cenra Inc is a Taiwan-based company mainly engaged in the provision of general investment related businesses. Through its subsidiary, the Company conducts the development, manufacturing and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products, as well as the import and sale of medical instruments. Its subsidiaries’ products are pharmaceuticals and health products, including human medicines, such as prescription and indicated drugs, over-the-counter medicines, and disease treatment products; medical equipment, such as blood pressure monitors, blood glucose meters, and artificial joints; animal medicines, supplementary feeds, and feed additives, providing animal treatment, disease prevention, and nutritional supplement products; daily necessities, such as toothpaste, tooth powder, mouthwash and other oral hygiene and health products, hand cleansers, dry hand sanitizers, shower gels, medicated soaps and lotion products, and skin care series.
Employees
-
Date Price Change Volume
26-07-23 NT$33.35 -3.75% 154,546
26-07-22 NT$34.65 +0.58% 263,234
26-07-21 NT$34.45 +0.88% 84,705
26-07-20 NT$34.15 +0.74% 132,550
26-07-17 NT$33.90 -1.74% 193,666
  1. Stock Market
  2. Stocks
  3. 3716 Stock